F. De Massis, A. Di Girolamo, A. Petrini, E. Pizzigallo, A. Giovannini

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study H.L. Nielsen, T. Ejlertsen, J. Engberg,

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus T. Bärnighausen, D.E. Bloom, E.T. Cafiero,

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

Sofie Arens, Jan Verhaegen, Ludo Verbist

Training for the infectious diseases speciality in Norway

Climatic factors and Pneumocystis jiroveci infection in southern Spain

M.N. Al-Hasan, B.D. Lahr, J.E. Eckel-Passow, L.M. Baddour

Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period P. Harris, D.-A. Siew, M. Proud, P. Buettner,

R. Karakus, K. Caglar, C. Aybay Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study H.L. Nielsen, T. Ejlertsen, J. Engberg,

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

G.R. Davies Clinical Microbiology and Infection

The practice of travel medicine in Europe

Update on antifungal resistance in Aspergillus and Candida

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Community-acquired pneumonia: epidemiologic and clinical consideration

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Training in infectious diseases and tropical medicine in Britain

D. Schönberg-Norio, S. Sarna, M. -L. Hänninen, M. -L. Katila, S. -S

Clinical infection services—the Leiden experience

Use of a multiplex real-time PCR to study the incidence of human metapneumovirus and human respiratory syncytial virus infections during two winter seasons.

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

F.J. Pastor, J. Guarro Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Are we losing the fight against malaria one more time?

The state of measles and rubella in the WHO European Region, 2013

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

L. Blairon, Y. De Gheldre, B. Delaere, A. Sonet, A. Bosly, Y

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Correlation between animal and human brucellosis in Italy during the period 1997–2002 F. De Massis, A. Di Girolamo, A. Petrini, E. Pizzigallo, A. Giovannini Clinical Microbiology and Infection Volume 11, Issue 8, Pages 632-636 (August 2005) DOI: 10.1111/j.1469-0691.2005.01204.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Number of expected cases of human brucellosis in a given age group related to a given percentage of occupational exposure risk. Clinical Microbiology and Infection 2005 11, 632-636DOI: (10.1111/j.1469-0691.2005.01204.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Relationship between the percentage of sheep and goat flocks positive for brucellosis and the incidence of human brucellosis in Italy (year 2002). Clinical Microbiology and Infection 2005 11, 632-636DOI: (10.1111/j.1469-0691.2005.01204.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Relationship between the monthly distribution of human cases of brucellosis in Italy and the percentage of lamb slaughters (1997–2002). A, secondary period of peak incidence (expected for occupational exposure). B, expected period of peak incidence for occupational exposure. C, expected period of peak incidence for foodborne exposure. Clinical Microbiology and Infection 2005 11, 632-636DOI: (10.1111/j.1469-0691.2005.01204.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 4 Expected distribution of the number of human cases of brucellosis in Italy by age class in relation to different levels of professional exposure. Clinical Microbiology and Infection 2005 11, 632-636DOI: (10.1111/j.1469-0691.2005.01204.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions